--------------------------------------------------------------------------------


Therapeutic Areas: Dermatology | Oncology

Keratoses Clinical Trials


A listing of Keratoses medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

California

Beverly Hills : Moy-Fincher-Chipps Facial Plastics/Dermatology Cedars Sinai

A clinical trial seeking patients for a research study for the treatment of Actinic Keratosis

Beverly Hills : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Irvine : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

La Jolla : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Walnut Creek : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Florida

West Palm Beach : Palm Beach Research Center New

Sun Spots (Actinic Keratosis)

Boca Raton : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Coral Gables : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Lake Worth : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Ormond Beach :

A clinical research study for the treatment of Actinic Keratosis

Tampa : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

West Palm Beach : Palm Beach Research

A clinical trial seeking patients for a research study for the treatment of Actinic Keratosis

Georgia

Atlanta : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Atlanta : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Atlanta : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Illinois

Chicago : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Indiana

Carmel : Laser & Skin Surgery Center of Inidana

A clinical research study of Ingenol mebutate gel and placebo for the treatment of Actinic Keratosis

Michigan

Warren : Grekin Skin Institute

A clinical trial seeking patients for a research study for the treatment of Actinic Keratosis

Missouri

St. Louis : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

New Jersey

Verona :

A clinical research study for the treatment of Actinic Keratosis

New York

New York : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

New York : Mount Sinai School of Medicine, Department of Dermatology, Clinical Trials

A Phase 4 clinical study for patients with Actinic Keratosis

Smithtown : Long Island Skin Cancer and Dermatologic Surgery

Patients are needed to participate in a clinical research study of ingenol mebutate to evaluate Actinic Keratosis

North Carolina

Raleigh : Wake Research Associates

Study of Actinic Keratosis

Huntersville : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Raleigh : Wake Research Associates

A clinical trial seeking patients for a research study for the treatment of Actinic Keratosis

Oregon

Eugene : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Tualatin : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Pennsylvania

Bala Cynwyd : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

South Carolina

South Dakota

Rapid City : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Texas

Houston : Suzanne Bruce and Associates,P.A. The Center for Skin Research

A clinical trial seeking patients for a research study for the treatment of Actinic Keratosis

San Antonio :

A clinical research study for the treatment of Actinic Keratosis

Sugar Land : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Virginia

Norfolk : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Washington

Spokane : Premier Clinical Research

A clinical trial seeking patients for a research study for the treatment of Actinic Keratosis

France

Nantes : Investigational site

A clinical research study of NDL-PDT, c-PDT and placebo c-PDT for the treatment of Actinic Keratoses

Rennes : Investigative site

A clinical research study of NDL-PDT, c-PDT and placebo c-PDT for the treatment of Actinic Keratoses

Germany

Aachen : Investigational site

A clinical research study of NDL-PDT, c-PDT and placebo c-PDT for the treatment of Actinic Keratoses

Berlin : Hautarztpraxis Simon

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Berlin : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Bochum : Hauttumorzentrum Bochum Universitätsklinikum der Ruhr-Universität-Bochum

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Buchholz : Praxis Streit Bucholz

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Dortmund : Klinikum Dortmund - Hautklinik

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Hamburg : Mensingderma

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Heidelberg : Universitätsklinikum Heidelberg/Klinische Sozialmedizin

A clinical trial seeking patients for a research study for the treatment of Actinic Keratosis

Kassel : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Leipzig : Universitätsklinikum Leipzig Klinik für Dermatologie, Venerologie und Allergologie

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Markkleeberg : Hautpraxis Dr. Ina Schulze

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Recklinghausen : Klinik für Dermatologie und Allergologie, Klinikum Vest, Behandlungszentrum, Knappschaftskrankenhaus Recklinghausen,

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Recklinghausen : Investigational site

A clinical research study of NDL-PDT, c-PDT and placebo c-PDT for the treatment of Actinic Keratoses

Witten : Praxis Dr. Hoffmann

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Wuppertal : Praxis Derma Hübinger

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Würzburg : Universitätsklinikum Würzburg

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Hungary

Budapest : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Debrecen : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Spain

Barcelona : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Barcelona : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Huesca : Investigational site

A clinical research study of NDL-PDT, c-PDT and placebo c-PDT for the treatment of Actinic Keratoses

Madrid : Pfizer Investigational Site

A Phase 2 clinical study for patients with Reduction of Hypertrophic Skin Scarring

Pamplona : Investigative site

A clinical research study of NDL-PDT, c-PDT and placebo c-PDT for the treatment of Actinic Keratoses

Taiwan

Chiayi : Chiayi Chang Gung Memorial Hospital Updated

A clinical trial to evaluate treatments using SR-T100 gel and Vehicle gel for patients with Actinic Keratosis

Kaohsiung : Kaohsiung Medical University Chung-Ho Memorial Hospital Updated

A clinical trial to evaluate treatments using SR-T100 gel and Vehicle gel for patients with Actinic Keratosis

Kaohsiung : Kaohsiung Veterans General Hospital Updated

A clinical trial to evaluate treatments using SR-T100 gel and Vehicle gel for patients with Actinic Keratosis

Kaohsiung : Kaohsiung Chang Gung Memorial Hospital Updated

A clinical trial to evaluate treatments using SR-T100 gel and Vehicle gel for patients with Actinic Keratosis

Tainan : National Cheng Kung University Hospital Updated

A clinical trial to evaluate treatments using SR-T100 gel and Vehicle gel for patients with Actinic Keratosis

Tainan : Chi Mei Medical Center YongKang Updated

A clinical trial to evaluate treatments using SR-T100 gel and Vehicle gel for patients with Actinic Keratosis

Tainan : National Cheng Kung University Hospital

Patients are needed to participate in a clinical research study of SR-T100 gel to evaluate Actinic Keratosis

United Kingdom

Airdrie : Monklands Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Borough of Brighton and Hove : Brighton General Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Bradford : St Luke's Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Cannock : Cannock Chase Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Carlisle : Cumberland Infirmary

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Dundee : Ninewells Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Exeter : Heavitree Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Manchester : Manchester Royal Infirmary

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Newport : Royal Gwent Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Redhill : East Surrey Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Scarborough : Scarborough Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Scunthorpe : Scunthorpe General Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

Shoreham-by-Sea : Southlands Hospital

A clinical research study of Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% for the treatment of Actinic Keratosis (AK)

---------------------------------------------------------------------------------

[ Home | Discussions | Article Archives | Help | Submit your Site]

Copyright 1996 - 2014 by Gelber Associates All Rights Reserved.